still need better blood sugar control; will follow their doctor's instructions exactly; will follow-up with their doctor often; will test their blood sugar levels before and after every meal, and at bedtime; and understand how to adjust Symlin and insulin doses.
Symlin should not be used if patients cannot tell when their blood sugar is low, have gastroparesis (slow stomach emptying), or are allergic to pramlintide acetate, metacresol, D-mannitol, acetic acid, or sodium acetate.
Side effects associated with Symlin include but are not limited to nausea, vomiting, abdominal pain, headache, fatigue and dizziness.
Symlin has not been evaluated in the pediatric population.
Symlin is manufactured by Amylin Pharmaceuticals, Inc. of San Diego, California.
'"/>Source:
US FDA
Page: 1 2 Related biology news :1.
FDA Approves Human Hookworm Vaccine for Phase I Safety Trials2.
FDA Approves New Treatment for Chronic Hepatitis B3.
Discovery Could Lead To Novel Approaches In HIV Treatment4.
New Treatment Rivals Chemotherapy For Lymphoma, Study Finds5.
Rush Physicians Using Gene Therapy For Heart Patients With Moderate To Severe Chest Pains Who Do Not Benefit From Other Treatments6.
Ophthalmologists Use Artificial Silicon Retina Microchip To Treat Vision Loss7.
Effective Cancer Treatments Follow The Clock8.
FDA Clears the Way for Generic Versions of Transdermal Patches to Treat Chronic Pain9.
Potential Drug Target For Treating Cocaine Abuse Found10.
Protein Discovery Could Unlock The Secret To Better TB Treatment11.
Embryonic Stem Cells Treated With Growth Factor Reverse Hemophilia In Mice: UNC Researchers